TRAM2 antisense RNA 1 (head to head) (TRAM2-AS1)

TRAM2 antisense RNA 1 (head to head), abbreviated as TRAM2-AS1, is a long non-coding RNA (lncRNA) located on chromosome 6p12[4]. It is categorized as an *intergenic* lncRNA—meaning it does not code for protein but acts as a regulatory RNA transcript. As an antisense RNA, its sequence is complementary to the TRAM2 gene mRNA, allowing it to participate in a wide range of RNA-based regulatory mechanisms, including regulation of the corresponding sense gene's transcription, influencing chromatin state, and modulating alternative splicing[1][3][4]. Although several antisense RNAs have been implicated in human disease, primarily cancer, no direct evidence firmly establishes TRAM2-AS1 as a validated therapeutic target, nor have specific drugs been developed to modulate its activity[6]. Its role is consistent with that of other lncRNAs and antisense transcripts, in which gene regulation is the principal function, especially at the level of gene expression and chromatin dynamics[1][3][4]. If you require disease-specific roles, mechanisms, or biomarker utility, more focused functional studies would be necessary to determine whether this transcript is actionable in a clinical or therapeutic setting.

Other names

TRAM2 antisense RNA 1TRAM2-AS1TRAM2 antisense RNA 1 (head to head)